Mumbai (Maharashtra) [India], February 24 (ANI): Equity benchmark indices jumped by nearly 2 per cent on Wednesday with banking and financial stocks gaining substantial ground.
New Delhi [India], February 24 (ANI): The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) is going to meet on Wednesday afternoon to discuss Dr Reddy's Laboratories application seeking emergency use approval (EUA) for SputnikV, a Russian Vaccine.
Mumbai (Maharashtra) [India], February 19 (ANI): Equity benchmark indices cracked further on Friday amid weak Asian cues with banking and auto majors taking a hit.
Hyderabad (Telangana) [India], Feb 19 (ANI): Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human adenoviral vector-based platform vaccine candidate Sputnik V.
Mumbai (Maharashtra) [India], Feb 3 (ANI): The bull roar continued at bourses on Wednesday with equity benchmark indices closing at record high peaks and exuberance over the Union Budget led to hopes of economic recovery among investors.
Mumbai (Maharashtra) [India], February 3 (ANI): Equity benchmark indices rose marginally during early hours on Wednesday with pharma stocks gaining ground.
Mumbai (Maharashtra) [India], January 29 (ANI): Equity benchmark indices swung between gains and losses in an extremely volatile trade on Friday as investors awaited the presentation of Union Budget next week.
Hyderabad (Telangana) [India], January 29 (ANI): Dr Reddy's Laboratories on Friday reported a consolidated net profit of Rs 20 crore for the October to December quarter as against a consolidated net loss of Rs 570 crore in the year-ago period.
Mumbai (Maharashtra) [India], January 15 (ANI): Equity benchmark indices were in the negative zone during early hours on Friday amid broad-based selling as traders booked profit.
Hyderabad (Telangana) [India], January 12 (ANI): Dr Reddy's Laboratories has said that independent Data and Safety Monitoring Board (DSMB) reviewed the safety data from phase two clinical trial of Russia's Covid-19 vaccine Sputnik V and recommended phase three recruitment along with continui
New Delhi [India], December 21 (ANI): Russia is working with India to jointly produce Sputnik V coronavirus vaccine at Dr Reddy's Laboratories for use in India, Russia and other countries, said Nikolay Kudashev, Russian Ambassador to India, on Monday.
Mumbai (Maharashtra) [India], December 18 (ANI): Equity benchmark indices reversed early losses and ended flat on Friday while trading in a narrow range amid mixed Asian trends, which defied a broader global rally.